Metastatic pheochromocytoma: An unusual case and its multidisciplinary management

J M Ruiz-Cánovas,E A Achote-Rea,T Alonso-Gordoa,A Martínez-Lorca,M Araujo-Castro
DOI: https://doi.org/10.1016/j.hipert.2024.09.002
2024-09-28
Abstract:We describe the case of an 80-year-old man with sporadic right pheochromocytoma who developed metastatic disease six years after initial diagnosis. Despite adequate blood pressure control and initial biochemical cure criteria after surgery, elevated chromogranin A levels were detected during routine screening, which anticipated elevated 24-h urine metanephrines. Subsequent imaging tests revealed metastatic lesions in the lungs, liver, prostate and lymph nodes. The patient underwent systemic treatment with [131I] MIBG, which resulted in a decrease in chromogranin A levels, achieving radiological and clinical stability. This case highlights the importance of long-term follow-up and biochemical monitoring for early detection of tumor recurrence in patients with pheochromocytoma, emphasizing the need for individualized treatment strategies and interdisciplinary care.
What problem does this paper attempt to address?